Do Stem Cell Injections Work?

Sometimes, partially, and mostly for knee osteoarthritis pain — but the honest answer is more complicated than most clinic websites suggest. Multiple randomized trials show that stem cell injections reduce knee pain and improve function better than placebo at 12 months (Yin et al., 2025).

However, a 2025 meta-analysis found that a substantial share of that improvement comes from contextual effects — the placebo response, attention from clinicians, and expectation — rather than from the cells themselves (Yin et al., 2025).

Stem cell injections are also not FDA-approved for any orthopedic condition (U.S. Food and Drug Administration, 2024b).

What This Means

"Does it work?" is really three separate questions, and they have different answers.

Does it reduce pain? For knee osteoarthritis, often yes — measurably more than saline in controlled trials. That is a real finding.

Does the improvement come from the stem cells specifically? This is where it gets murky.

When researchers looked closely at what drives the improvement, they found the therapeutic context — believing you received an advanced treatment, the ritual of the procedure, close follow-up — accounts for a large portion of the benefit (Yin et al., 2025).

The cells may contribute something on top of that, but the size of that specific contribution is genuinely uncertain.

Does it rebuild cartilage or reverse arthritis? Largely no. Evidence for actual cartilage volume restoration is limited and inconsistent, even where symptoms improve.

That distinction matters practically. If your goal is feeling better for a while, the odds are not unreasonable. If your goal is regrowing a joint and avoiding replacement permanently, the evidence does not support that expectation.

Who May or May Not Be a Reasonable Candidate

More reasonable candidates: adults with mild to moderate knee osteoarthritis or a localized tendon injury, who have already tried physical therapy and other conservative measures, who understand the treatment is investigational, and who are seeking symptom relief rather than structural cure.

Less reasonable candidates: people with severe, bone-on-bone joint degeneration, where the mechanical problem is beyond what any injection realistically addresses. Joint replacement generally serves these patients better.

Poor candidates: anyone with an active infection, active cancer, or uncontrolled systemic illness; anyone seeking intravenous stem cell infusion for neurological, autoimmune, or age-related conditions outside a registered clinical trial.

A note on expectations: if a clinic promises cartilage regrowth, guaranteed results, or tells you that you are certainly a candidate before examining you or reviewing imaging, be skeptical.

How Clinicians Actually Evaluate Candidacy

A responsible workup should feel unhurried and specific to you.

Expect a full history and physical exam covering symptom duration, what treatments you have already tried, and what functional goals matter to you — climbing stairs, walking a certain distance, sleeping without pain.

Expect weight-bearing X-rays to grade the severity of joint space narrowing, and often MRI to assess cartilage, meniscus, and soft tissue. The severity grade matters, because response rates differ substantially between early and advanced disease.

Expect basic labs to screen for infection or uncontrolled diabetes, and a medication review covering anticoagulants and immunosuppressants. Expect a frank discussion of alternatives, including doing nothing.

In Florida, physicians offering non-FDA-approved stem cell therapy must obtain signed informed consent disclosing that the therapy is not FDA-approved, along with anticipated results, recognized risks, potential benefits, and alternative options including declining the procedure.

Physicians are also required to encourage patients to consult their primary care provider first (Fla. Stat. . 458.3245, 2025).

Available Options, Including Conventional Care

Stem cell injection is one option, and for most patients it should not be the first.

Well-established conventional options include:

• Structured physical therapy and targeted strengthening, which has strong evidence for knee osteoarthritis
• Weight management and activity modification
• NSAIDs and other analgesics
• Corticosteroid injections for short-term flares
• Hyaluronic acid injections and bracing

For advanced disease, joint replacement is extensively studied with predictable, durable outcomes.

Investigational regenerative options include platelet-rich plasma (PRP), bone marrow aspirate concentrate, adipose-derived preparations, and exosome therapy. Note that there are currently no FDA-approved exosome products, and the FDA has issued specific safety warnings about them (U.S. Food and Drug Administration, 2024a).

Clinical trials: academic centers run monitored trials with oversight and structured follow-up, often at no cost for the investigational product. ClinicalTrials.gov is searchable by condition and location.

One useful comparative data point: a 2025 meta-analysis in Arthroscopy found mesenchymal stem cell injections outperformed hyaluronic acid injections for knee function and pain, with comparable safety (Jin et al., 2025).

That is a meaningful signal — though it compares against another injection rather than against physical therapy or surgery.

Benefits, Limitations, and Risks — Stated Plainly

Potential Benefits

Meaningful pain reduction and functional improvement for some patients with knee osteoarthritis, sustained in trials out to about 12 months. Outpatient procedure with short recovery relative to surgery.

Short-term safety in controlled settings has generally been acceptable, with no significant increase in treatment-related adverse events versus placebo in pooled analyses (Yin et al., 2025).

Limitations and Risks

Much of the measured benefit may be contextual rather than biological (Yin et al., 2025). There is no standardized cell dose, source, or preparation protocol, which makes studies hard to compare and results hard to reproduce across clinics. Effects on actual cartilage volume are limited.

Durability beyond 12–24 months is poorly characterized. Insurance almost never covers it, so costs are out of pocket for an unproven intervention.

Injection carries infection, bleeding, and post-procedure pain and swelling risk.

More seriously, the FDA has received reports of blindness, tumor formation, and severe infections associated with unapproved stem cell products, particularly with non-orthopedic administration routes (U.S. Food and Drug Administration, 2024a).

Products from facilities lacking proper FDA registration and accreditation add contamination risk.

What the Evidence Does and Does Not Show

What the evidence does establish: Stem cell injections outperform inert placebo for knee osteoarthritis pain and function at 12 months in pooled randomized trial data (Yin et al., 2025).

They compare favorably to hyaluronic acid injection on function and pain with similar safety (Jin et al., 2025). Short-term safety in monitored settings is generally acceptable.

What the evidence does not establish: That the cells themselves drive most of the benefit — contextual effects appear to account for a substantial portion (Yin et al., 2025). That injections regrow cartilage or reverse arthritis. That benefits persist beyond one to two years.

That any specific commercial preparation is superior to another, since dosing and processing vary widely. That stem cell injections help non-orthopedic conditions, aging, or systemic disease.

The honest summary: promising and worth studying for knee osteoarthritis symptoms; unproven as a structural cure; and actively oversold in much of the marketing patients encounter.

Recovery and Next Steps

Most joint injections are outpatient, and patients typically walk out the same day. Soreness and swelling at the injection site over the first several days is common and expected.

Many providers advise limiting high-impact activity for one to two weeks, then a graded return, often paired with physical therapy — which likely matters more to the outcome than patients assume.

Where improvement occurs, patients generally describe it developing over several weeks to a few months rather than immediately. It varies considerably between individuals and is not guaranteed.

Practical next steps:

• Ask for the informed consent document before your appointment and read it carefully.
• Ask what specific cell product is being used, its source, and whether the facility is FDA-registered and accredited.
• Ask what the published evidence shows for your specific grade of arthritis.
• Search ClinicalTrials.gov for a registered trial matching your condition.
• Talk with your primary care physician, as Florida law directs providers to encourage (Fla. Stat. § 458.3245, 2025).

Orlando and Florida Considerations

Florida is a distinctive environment for this treatment, and Orlando patients should understand why.

Effective July 1, 2025, Florida law permits licensed MDs and DOs to perform stem cell therapies that are not FDA-approved — but only for orthopedic conditions, wound care, or pain management (Fla. Stat. § 458.3245, 2025). The statute imposes real conditions:

• Cells must come from a facility registered with the FDA and accredited by a recognized body such as the American Association of Tissue Banks or the Association for the Advancement of Blood and Biotherapies.
• A post-thaw viability report must reach the physician before use.
• Signed informed consent is mandatory.
• Advertisements for non-FDA-approved stem cell therapy must carry a disclosure notice in a type size no smaller than the largest font in the ad.

An important caveat frequently glossed over in local marketing: a state law permitting a practice does not override federal authority over the product itself.

FDA regulation of cell and tissue products applies in Florida as everywhere, and legal analysts have noted the tension the state law creates (Holland & Knight, 2025).

Florida's dense concentration of regenerative clinics and large retiree population make this a heavily marketed space — which is all the more reason to read the mandated disclosure carefully rather than mistaking the state law for evidence of efficacy. It is not.

Frequently Asked Questions

How long do stem cell injections take to work?

Where improvement occurs, patients typically report it developing gradually over several weeks to a few months, not immediately. Trial data most often measures outcomes at 6 and 12 months. Timelines vary and improvement is not guaranteed.

Are stem cell injections FDA approved?

Not for orthopedic conditions. No stem cell product is FDA-approved for knee, back, hip, or shoulder problems. FDA-approved stem cell products are limited to blood-forming stem cells from umbilical cord blood for disorders affecting blood production (U.S. Food and Drug Administration, 2024b).

Do stem cell injections work better than cortisone or hyaluronic acid?

Compared with hyaluronic acid, a 2025 meta-analysis found stem cell injections improved knee function and pain more, with similar safety (Jin et al., 2025). Head-to-head comparisons against corticosteroid injection and against structured physical therapy are less well established.

Does insurance cover stem cell injections?

Generally no. Because they are considered investigational for orthopedic use, commercial insurers and Medicare typically do not cover them, making this an out-of-pocket expense.

Can stem cell injections help me avoid knee replacement?

There is no reliable evidence that they prevent or indefinitely postpone joint replacement, particularly in advanced arthritis. Any clinic presenting them as a guaranteed alternative to surgery is overstating what the research supports.

References

Fla. Stat. § 458.3245. (2025). Stem cell therapy. The Florida Senate. https://www.flsenate.gov/Laws/Statutes/2025/458.3245

Holland & Knight. (2025, August). New Florida law attempts to provide leeway for certain stem cell treatments. https://www.hklaw.com/en/insights/publications/2025/08/new-florida-law-attempts-to-provide-leeway-for-certain-stem-cell

Jin, W.-S., Yin, L.-X., Sun, H.-Q., Zhao, Z., & Yan, X.-F. (2025).

Mesenchymal stem cells injection is more effective than hyaluronic acid injection in the treatment of knee osteoarthritis with similar safety: A systematic review and meta-analysis.

Arthroscopy: The Journal of Arthroscopic & Related Surgery, 41(2), 318–332. https://doi.org/10.1016/j.arthro.2024.07.027

U.S. Food and Drug Administration. (2024a). Consumer alert on regenerative medicine products including stem cells and exosomes. https://www.fda.gov/vaccines-blood-biologics/consumers-biologics/consumer-alert-regenerative-medicine-products-including-stem-cells-and-exosomes

U.S. Food and Drug Administration. (2024b). Important patient and consumer information about regenerative medicine therapies. https://www.fda.gov/vaccines-blood-biologics/consumers-biologics/important-patient-and-consumer-information-about-regenerative-medicine-therapies

Yin, Y., Wu, S., Tong, W., Luo, J., Deng, Y., Yan, X., & Zhang, X. (2025). Contextual effects of mesenchymal stem cell injections for knee osteoarthritis: Systematic review and meta-analysis of randomized controlled trials. Frontiers in Medicine, 12. https://doi.org/10.3389/fmed.2025.1636181

If you would like help sorting out whether this is a reasonable option for your specific joint problem, our team in Orlando is glad to talk it through with you. Schedule a consultation with PrimeCell Regenerative when you're ready.

This article is provided for educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations. Stem cell therapies offered outside FDA-approved indications or authorized clinical trials are investigational and are not FDA-approved to cure, treat, or prevent any specific disease.

Individual results vary, and no outcome is guaranteed. Please consult a licensed physician about your specific situation before pursuing any treatment discussed here. Medically reviewed by Kenny Chantasi, DO. Last medically reviewed: August 10, 2026.

Related reading

• How Does Stem Cell Therapy Work?
• How Long Is Recovery After Stem Cell Therapy?
• Stem Cells for Hearing Loss: What Research Shows
• How Medical Weight Loss Works

More questions answered on the PrimeCell patient blog, or see frequently asked questions.

Related services at PrimeCell

PrimeCell is a physician-led practice in Orlando. Candidacy for any procedure is determined at an in-person evaluation.